201
Participants
Start Date
March 31, 2014
Primary Completion Date
June 30, 2016
Study Completion Date
August 31, 2016
Brincidofovir
BCV administered twice weekly, dose depending on weight.
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical College/ New York Presbyterian Hospital, New York
Montifore Medical Center, The Bronx
Children's Hospital of Pittsburgh, Pittsburgh
Fred Hutchingson Cancer Center, Seattle
Children's Hospital of Philadelphia, Philadelphia
Children's National Health System, Washington D.C.
Johns Hopkins University, Baltimore
Duke University Medical Center, Durham
Levine Children's Hospital, Charlotte
Children's Healthcare of Atlanta, Aflac Cancer and Blood Center, Atlanta
St. Jude Children's Hospital, Memphis
Cincinnati Children's Hospital, Cincinnati
Medical College of Wisconsin, Milwaukee
University of Minnesota, Minneapolis
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
University of Chicago, Chicago
Washington University School of Medicine, St Louis
Children's Mercy Hospital, Kansas City
University of Nebraska, Omaha
Children's Hospital, New Orleans
Cook Children's Medical Center, Fort Worth
Baylor College of Medicine, Houston
MD Anderson Cancer Center, Houston
Children's Hospital Colorado, Aurora
Intermountain Healthcare Research, Salt Lake City
University of Utah Huntsman Cancer Institute, Salt Lake City
Phoenix Children's Hospital, Phoenix
Children's Hospital Los Angeles, Los Angeles
Stanford Children's Hospital, Palo Alto
Stanford University, Stanford
Seattle Children's Hospital, Seattle
Brigham and Woman's Hospital, Boston
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY